Clinical Trials Directory

Trials / Sponsors / Telios Pharma, Inc.

Telios Pharma, Inc.

Industry · 11 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingEvaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis
Allergic Conjunctivitis
Phase 22025-10-23
RecruitingEvaluation of TL-925 for the Treatment of Allergic Conjunctivitis
Allergic Conjunctivitis
Phase 22024-10-03
CompletedA Study Of TL-925 For The Treatment of AC
Allergic Conjunctivitis
Phase 22024-04-11
Active Not RecruitingA Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease
Dry Eye Disease
Phase 22024-02-06
UnknownA Study of TL-925 for the Treatment of Allergic Conjunctivitis
Allergic Conjunctivitis
Phase 22023-11-01
CompletedA Study of TL-925 as a Treatment for Dry Eye Disease
Dry Eye Disease
Phase 22023-02-27
RecruitingStudy of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a
Myelofibrosis, Primary Myelofibrosis, Post-PV MF
Phase 1 / Phase 22022-06-09
UnknownTL-895 and KRT-232 Study in Acute Myeloid Leukemia
Acute Myeloid Leukemia
Phase 1 / Phase 22021-03-31
RecruitingStudy of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
Myelofibrosis, Indolent Systemic Mastocytosis
Phase 22020-10-22
CompletedA Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of C
COVID-19, Sars-CoV2, Cancer
Phase 12020-07-09
UnknownPhase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy W
Relapsed/Refractory B Cell Malignancies, Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia
Phase 1 / Phase 22016-08-26